- Home
- ABOS vs MAPS Comparison
ABOS vs MAPS Comparison
Compare ABOS & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABOS | MAPS |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.9M | 106.3M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABOS | MAPS |
|---|---|---|
| Price | $1.96 | $0.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $7.67 | $2.61 |
| AVG Volume (30 Days) | 139.2K | ★ 754.1K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $179,305,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.23 |
| P/E Ratio | ★ N/A | $13.31 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.86 | $0.72 |
| 52 Week High | $2.46 | $1.65 |
Technical Indicators
Market Signals| Indicator | ABOS | MAPS |
|---|---|---|
| Relative Strength Index (RSI) | 54.12 | 53.67 |
| Support Level | $1.85 | $0.85 |
| Resistance Level | $2.02 | $0.92 |
| Average True Range (ATR) | 0.13 | 0.04 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 87.00 | 96.77 |
Price Performance
Historical ComparisonAbout ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises the B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on marketplace ads.